About Atossa Genetics (ATOS)

The stock price history of Atossa Genetics Inc (ATOS) has seen its fair share of ups and downs. Over the years, the stock has experienced significant volatility, with fluctuations in both the short term and the long term. Investors interested in ATOS should be aware of its historical performance and the factors that have influenced its price movements. From its initial public offering in 2012 to the present day, ATOS has experienced several notable price spikes and declines. For example, in 2013, the stock saw a significant increase in value, reaching a peak of $12.50 per share. However, this was followed by a sharp decline, with the stock price dropping to just $0.70 per share in 2014. Since then, the stock price has continued to fluctuate, but has yet to reach the highs seen in 2013. As of the most recent trading session, ATOS is priced at $3.25 per share.

In terms of news, Atossa Genetics Inc (ATOS) has made some significant announcements in recent months. One notable development was the company's collaboration with a leading pharmaceutical company to develop a potential treatment for breast cancer. This partnership has generated a lot of excitement among investors, as breast cancer is a pressing health issue that affects millions of women worldwide. Furthermore, ATOS has been actively involved in research and development efforts to identify novel therapeutic candidates for various diseases. The company's dedication to innovation and its focus on addressing critical medical needs have been among the key drivers of its stock performance.